Utilization of galactose by human platelets in vitro

Area of Science:

• Biochemistry
• Hematology
• Cellular Metabolism

Background:

• The metabolic fate of galactose within platelets remains largely uncharacterized.
• Understanding platelet metabolism is crucial for comprehending their function in hemostasis and thrombosis.

Purpose of the Study:

• To investigate the capacity of human platelets to metabolize galactose.
• To identify the metabolic products of galactose within platelets and elucidate the nature of their incorporation.

Main Methods:

• Incubation of isolated human platelets with radiolabeled galactose.
• Analysis of radioactive metabolites using thin-layer chromatography and Sepharose CL-4B chromatography.
• Assessment of trichloroacetic acid (TCA) precipitable radioactivity and its degradation by alpha-amylase and protease.
• Investigation of metabolic pathway reversibility using unlabeled galactose and platelet agonists (thrombin, collagen).

Main Results:

• Galactose rapidly accumulated in platelets and was quickly metabolized.
• Radioactivity was detected in TCA precipitates, indicating incorporation into macromolecules.
• TCA-precipitable radioactivity was degraded by alpha-amylase and protease, suggesting both carbohydrate and protein components.
• TCA-soluble material, released by protease, was degraded by alpha-amylase, indicating it was not glycopeptide.
• The majority of metabolized galactose was incorporated into glycogen, not glycoprotein.
• Galactose metabolism in platelets was reversible and affected by thrombin and collagen stimulation.

Conclusions:

• Human platelets possess the metabolic machinery to process galactose.
• Galactose is primarily incorporated into platelet glycogen, with minimal incorporation into glycoproteins.
• The galactose metabolic pathway in platelets is dynamic, reversible, and responsive to physiological stimuli.